Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs.

MLA

Similon, Miriam von Mücke, et al. “Expert Consensus Recommendations on the Use of Randomized Clinical Trials for Drug Approval in Psychiatry- Comparing Trial Designs.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, vol. 60, July 2022, pp. 91–99. EBSCOhost, https://doi.org/10.1016/j.euroneuro.2022.05.002.

APA

Similon, M. von M., Paasche, C., Krol, F., Lerer, B., Goodwin, G. M., Berk, M., Meyer-Lindenberg, A., Ketter, T. A., Yatham, L. N., Goldberg, J. F., Malhi, G. S., El-Mallakh, R., Licht, R. W., Young, A. H., Kapczinski, F., Swartz, M., Hagin, M., Torrent, C., Serretti, A., … Popovic, D. (2022). Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology, 60, 91–99. https://doi.org/10.1016/j.euroneuro.2022.05.002

Chicago

Similon, Miriam von Mücke, Cecilia Paasche, Fas Krol, Bernard Lerer, Guy M Goodwin, Michael Berk, Andreas Meyer-Lindenberg, et al. 2022. “Expert Consensus Recommendations on the Use of Randomized Clinical Trials for Drug Approval in Psychiatry- Comparing Trial Designs.” European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 60 (July): 91–99. doi:10.1016/j.euroneuro.2022.05.002.